A carregar...
Photorelease of a Metal-Binding Pharmacophore from a Ru(II) Polypyridine Complex
The adoption of compounds that target metalloenzymes comprises a relatively low (<5%) percentage of all FDA approved therapeutics. Metalloenzyme inhibitors typically coordinate to the active site metal ions and therefore contain ligands with charged or highly polar functional groups. While these...
Na minha lista:
| Publicado no: | Dalton Trans |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7944940/ https://ncbi.nlm.nih.gov/pubmed/33564808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/d0dt04290k |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|